Annual SGA
$27.43 M
+$7.31 M+36.34%
December 31, 2021
Summary
- As of February 9, 2025, SRRA annual SGA is $27.43 million, with the most recent change of +$7.31 million (+36.34%) on December 31, 2021.
- During the last 3 years, SRRA annual SGA has risen by +$13.10 million (+91.33%).
Performance
SRRA SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly SGA
$10.33 M
+$2.17 M+26.57%
March 31, 2022
Summary
- As of February 9, 2025, SRRA quarterly SGA is $10.33 million, with the most recent change of +$2.17 million (+26.57%) on March 31, 2022.
- Over the past year, SRRA quarterly SGA has increased by +$4.46 million (+76.11%).
Performance
SRRA Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM SGA
-$3.71 B
-$102.67 M-2.84%
March 31, 2022
Summary
- As of February 9, 2025, SRRA TTM SGA is -$3.71 billion, with the most recent change of -$102.67 million (-2.84%) on March 31, 2022.
- Over the past year, SRRA TTM SGA has dropped by -$3.73 billion (-17416.45%).
Performance
SRRA TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
SRRA Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.3% | +76.1% | -10000.0% |
| 3 y3 years | +91.3% | +206.9% | -10000.0% |
| 5 y5 years | +120.2% | +228.3% | -10000.0% |
SRRA Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | -21.0% | +2.8% | at low |
| 5 y | 5-year | at high | -49.9% | at high | -63.7% | +28.9% | at low |
| alltime | all time | at high | -95.8% | at high | -95.2% | +3344.4% | at low |
Sierra Oncology Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $10.33 M(+26.6%) | $31.90 M(+16.3%) |
| Dec 2021 | $27.43 M(+36.3%) | $8.16 M(+16.8%) | $27.43 M(+12.1%) |
| Sep 2021 | - | $6.99 M(+8.7%) | $24.48 M(+13.3%) |
| Jun 2021 | - | $6.42 M(+9.5%) | $21.61 M(+0.8%) |
| Mar 2021 | - | $5.87 M(+12.6%) | $21.44 M(+6.6%) |
| Dec 2020 | $20.12 M(+46.4%) | $5.21 M(+26.6%) | $20.12 M(+7.8%) |
| Sep 2020 | - | $4.11 M(-34.3%) | $18.66 M(+5.4%) |
| Jun 2020 | - | $6.26 M(+37.8%) | $17.70 M(+18.6%) |
| Mar 2020 | - | $4.54 M(+21.2%) | $14.92 M(+8.6%) |
| Dec 2019 | $13.74 M(-4.2%) | $3.75 M(+18.9%) | $13.74 M(+1.1%) |
| Sep 2019 | - | $3.15 M(-9.4%) | $13.60 M(+0.1%) |
| Jun 2019 | - | $3.48 M(+3.4%) | $13.59 M(-4.9%) |
| Mar 2019 | - | $3.37 M(-6.6%) | $14.28 M(-0.4%) |
| Dec 2018 | $14.34 M(+15.1%) | $3.60 M(+14.8%) | $14.34 M(+2.5%) |
| Sep 2018 | - | $3.14 M(-24.9%) | $13.99 M(+2.6%) |
| Jun 2018 | - | $4.18 M(+22.2%) | $13.63 M(+7.0%) |
| Mar 2018 | - | $3.42 M(+5.1%) | $12.74 M(+2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $12.46 M(-12.1%) | $3.25 M(+17.2%) | $12.46 M(-1.2%) |
| Sep 2017 | - | $2.78 M(-15.4%) | $12.62 M(-1.4%) |
| Jun 2017 | - | $3.28 M(+4.4%) | $12.80 M(-4.1%) |
| Mar 2017 | - | $3.15 M(-7.8%) | $13.35 M(-5.9%) |
| Dec 2016 | $14.18 M(+49.7%) | $3.41 M(+15.3%) | $14.18 M(-0.0%) |
| Sep 2016 | - | $2.96 M(-22.7%) | $14.19 M(+1.6%) |
| Jun 2016 | - | $3.83 M(-3.7%) | $13.96 M(+16.3%) |
| Mar 2016 | - | $3.98 M(+16.3%) | $12.01 M(+26.8%) |
| Dec 2015 | $9.47 M(+170.6%) | $3.42 M(+24.9%) | $9.47 M(+31.1%) |
| Sep 2015 | - | $2.74 M(+46.1%) | $7.23 M(+30.6%) |
| Jun 2015 | - | $1.87 M(+30.0%) | $5.53 M(+24.3%) |
| Mar 2015 | - | $1.44 M(+22.8%) | $4.45 M(+27.1%) |
| Dec 2014 | $3.50 M(+201.2%) | $1.17 M(+12.5%) | $3.50 M(+50.4%) |
| Sep 2014 | - | $1.04 M(+31.9%) | $2.33 M(+81.2%) |
| Jun 2014 | - | $791.00 K(+60.4%) | $1.28 M(+160.4%) |
| Mar 2014 | - | $493.00 K | $493.00 K |
| Dec 2013 | $1.16 M | - | - |
FAQ
- What is Sierra Oncology annual SGA?
- What is the all time high annual SGA for Sierra Oncology?
- What is Sierra Oncology annual SGA year-on-year change?
- What is Sierra Oncology quarterly SGA?
- What is the all time high quarterly SGA for Sierra Oncology?
- What is Sierra Oncology quarterly SGA year-on-year change?
- What is Sierra Oncology TTM SGA?
- What is the all time high TTM SGA for Sierra Oncology?
- What is Sierra Oncology TTM SGA year-on-year change?
What is Sierra Oncology annual SGA?
The current annual SGA of SRRA is $27.43 M
What is the all time high annual SGA for Sierra Oncology?
Sierra Oncology all-time high annual SGA is $27.43 M
What is Sierra Oncology annual SGA year-on-year change?
Over the past year, SRRA annual SGA has changed by +$7.31 M (+36.34%)
What is Sierra Oncology quarterly SGA?
The current quarterly SGA of SRRA is $10.33 M
What is the all time high quarterly SGA for Sierra Oncology?
Sierra Oncology all-time high quarterly SGA is $10.33 M
What is Sierra Oncology quarterly SGA year-on-year change?
Over the past year, SRRA quarterly SGA has changed by +$4.46 M (+76.11%)
What is Sierra Oncology TTM SGA?
The current TTM SGA of SRRA is -$3.71 B
What is the all time high TTM SGA for Sierra Oncology?
Sierra Oncology all-time high TTM SGA is -$107.81 M
What is Sierra Oncology TTM SGA year-on-year change?
Over the past year, SRRA TTM SGA has changed by -$3.73 B (-17416.45%)